128 related articles for article (PubMed ID: 12181257)
21. Interstitial pneumonitis after oxaliplatin treatment in colorectal cancer.
Yagüe XH; Soy E; Merino BQ; Puig J; Fabregat MB; Colomer R
Clin Transl Oncol; 2005 Dec; 7(11):515-7. PubMed ID: 16373064
[TBL] [Abstract][Full Text] [Related]
22. Atypical presentation of fever as hypersensitivity reaction to oxaliplatin.
Khurana A; Mitsis D; Kowlgi GN; Holle LM; Clement JM
J Oncol Pharm Pract; 2016 Apr; 22(2):319-24. PubMed ID: 25361599
[TBL] [Abstract][Full Text] [Related]
23. Protection against oxaliplatin acute neurosensory toxicity by venlafaxine.
Durand JP; Brezault C; Goldwasser F
Anticancer Drugs; 2003 Jul; 14(6):423-5. PubMed ID: 12853883
[TBL] [Abstract][Full Text] [Related]
24. [Efficacy and side effects of combination therapy of oxaliplatin and S-1 for colorectal cancer].
Zhu QC; Jin ZM
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):388-90. PubMed ID: 21875473
[TBL] [Abstract][Full Text] [Related]
25. Severe anaphylactic reactions to oxaliplatin.
Tournigand C; Maindrault-Goebel F; Louvet C; de Gramont A; Krulik M
Eur J Cancer; 1998 Jul; 34(8):1297-8. PubMed ID: 9849497
[No Abstract] [Full Text] [Related]
26. Reversible bilateral blepharoptosis following oxaliplatin infusion: a case report and literature review.
Fanetti G; Ferrari LA; Pietrantonio F; Buzzoni R
Tumori; 2013; 99(5):e216-9. PubMed ID: 24501793
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of heated intraperitoneal oxaliplatin.
Ferron G; Dattez S; Gladieff L; Delord JP; Pierre S; Lafont T; Lochon I; Chatelut E
Cancer Chemother Pharmacol; 2008 Sep; 62(4):679-83. PubMed ID: 18084764
[TBL] [Abstract][Full Text] [Related]
28. Oxaliplatin-induced proximal renal tubular acidosis.
Negro A; Grasselli C; Galli P
Intern Emerg Med; 2010 Jun; 5(3):267-8. PubMed ID: 19937480
[No Abstract] [Full Text] [Related]
29. Oxaliplatin-induced haematological emergency with an immediate severe thrombocytopenia and haemolysis.
Sørbye H; Bruserud Y; Dahl O
Acta Oncol; 2001; 40(7):882-3. PubMed ID: 11859992
[No Abstract] [Full Text] [Related]
30. Mass spectrometry study of hemoglobin-oxaliplatin complexes in colorectal cancer patients and potential association with chemotherapeutic responses.
Mandal R; Sawyer MB; Li XF
Rapid Commun Mass Spectrom; 2006; 20(17):2533-8. PubMed ID: 16878345
[TBL] [Abstract][Full Text] [Related]
31. Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer.
de Gramont A; Vignoud J; Tournigand C; Louvet C; André T; Varette C; Raymond E; Moreau S; Le Bail N; Krulik M
Eur J Cancer; 1997 Feb; 33(2):214-9. PubMed ID: 9135491
[TBL] [Abstract][Full Text] [Related]
32. [Acute idiopathic polyneuritis: a potentially fatal neuropathy that is difficult to diagnose in patients receiving oxaliplatin].
Trabut JB; Brezault C; Chaussade S; Lamarque D
Gastroenterol Clin Biol; 2007 Feb; 31(2):198-9. PubMed ID: 17347631
[No Abstract] [Full Text] [Related]
33. Cytotoxicity, cellular uptake, and cellular biotransformations of oxaliplatin in human colon carcinoma cells.
Luo FR; Wyrick SD; Chaney SG
Oncol Res; 1998; 10(11-12):595-603. PubMed ID: 10367941
[TBL] [Abstract][Full Text] [Related]
34. Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy.
Lehky TJ; Leonard GD; Wilson RH; Grem JL; Floeter MK
Muscle Nerve; 2004 Mar; 29(3):387-92. PubMed ID: 14981738
[TBL] [Abstract][Full Text] [Related]
35. Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07.
Land SR; Kopec JA; Cecchini RS; Ganz PA; Wieand HS; Colangelo LH; Murphy K; Kuebler JP; Seay TE; Needles BM; Bearden JD; Colman LK; Lanier KS; Pajon ER; Cella D; Smith RE; O'Connell MJ; Costantino JP; Wolmark N
J Clin Oncol; 2007 Jun; 25(16):2205-11. PubMed ID: 17470850
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of intraperitoneal oxaliplatin: experimental studies.
Pestieau SR; Belliveau JF; Griffin H; Stuart OA; Sugarbaker PH
J Surg Oncol; 2001 Feb; 76(2):106-14. PubMed ID: 11223836
[TBL] [Abstract][Full Text] [Related]
37. Sudden hearing loss due to oxaliplatin use in a patient with colon cancer.
Güvenç MG; Dizdar D; Dizdar SK; Okutur SK; Demir G
J Chemother; 2016 Aug; 28(4):341-2. PubMed ID: 25872564
[TBL] [Abstract][Full Text] [Related]
38. Oxaliplatin-induced acute tubulointerstitial nephritis: Two case reports
.
Choi YJ; Oh KH; Kang HR; Lee SJ
Clin Nephrol; 2018 Feb; 89(2):130-134. PubMed ID: 29231160
[TBL] [Abstract][Full Text] [Related]
39. New therapeutic options in colon cancer: focus on oxaliplatin.
Wilkes GM
Clin J Oncol Nurs; 2002; 6(3):131-7. PubMed ID: 11998605
[TBL] [Abstract][Full Text] [Related]
40. Safety and toxicity analysis of oxaliplatin combined with fluorouracil or as a single agent in patients with previously treated advanced colorectal cancer.
Ramanathan RK; Clark JW; Kemeny NE; Lenz HJ; Gococo KO; Haller DG; Mitchell EP; Kardinal CG
J Clin Oncol; 2003 Aug; 21(15):2904-11. PubMed ID: 12885808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
